Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Episodes 1-16 of 159

Diagnosis and Management of Metastatic PDAC
Diagnosis and Management of Metastatic PDAC
MinuteCE®
Diagnosis and Management of Metastatic PDAC
0.25 program credits
- Efrat Dotan, MD
- Shubham Pant, MD, MBBS
0.25 program credits
MinuteCE®
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment
0.25 credits 2 episodes
- Efrat Dotan, MD
- Shubham Pant, MD, MBBS
0.25 credits 2 episodes
Chemotherapy Strategies for Metastatic PDAC
Chemotherapy Strategies for Metastatic PDAC
MinuteCE®
Chemotherapy Strategies for Metastatic PDAC
0.25 program credits
- Efrat Dotan, MD
- Shubham Pant, MD, MBBS
0.25 program credits
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Project Oncology®
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
- Charles Turck, PharmD, BCPS, BCCCP
- Matthew Matasar, MD
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Project Oncology®
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
- Charles Turck, PharmD, BCPS, BCCCP
- Paolo Tarantino, MD
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Project Oncology®
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
- Charles Turck, PharmD, BCPS, BCCCP
- Sairah Ahmed, MD
- Caron A. Jacobson, MD
Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Global Oncology Academy
Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Project Oncology®
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
- Tara Graff, DO, MS
- Charles Turck, PharmD, BCPS, BCCCP
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Project Oncology®
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
- Jacob Sands, MD
- Julia Rotow, MD
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Project Oncology®
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
Project Oncology®
Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges
- Adrienne Waks, MD
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Project Oncology®
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
- Charles Turck, PharmD, BCPS, BCCCP
- Thomas Egenod, MD
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Project Oncology®
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
- Jacob Sands, MD
- Aaron Lisberg, MD
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Project Oncology®
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
- Ben Park, MD, PhD
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Project Oncology®
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
- Jacob Sands, MD
- Aaron Lisberg, MD